AXSM News and Press, Axsome Therapeutics Inc. From 06/28/23

2023-06-28 09:25:19 ET The stock market has treated investors well so far in 2023, and although the past couple of weeks have been a bit more turbulent, the Nasdaq Composite (NASDAQINDEX: ^IXIC) gave Wall Street a gain of more than 1.5% on Tuesday. Wednesday morning looks a bit less...

2023-06-28 08:18:51 ET AST SpaceMobile ( ASTS ) -30% on pricing upsized $59.4M equity offering. American Rebel Holdings ( AREB ) -27% . Eton Pharmaceuticals ( ETON ) -15% as FDA rejects methanol poisoning therapy . Centogene ( CNTG ) -12% ...

2023-06-28 07:45:00 ET There are plenty of well-known biotech giants that look like solid investments. But targeting smaller and relatively unknown companies in the industry could provide much juicier returns over the long run. Of course, smaller biotechs tend to be riskier investments, so ...

2023-06-28 03:14:41 ET Axsome Therapeutics ( NASDAQ: AXSM ) said Tuesday it plans to conduct a public offering of its common stock. The underwriters are expected to have a 30-day option to purchase up to an additional 15% of the shares of common stock. All of the...

2023-06-25 06:07:00 ET What's small today could become huge in the future. That's especially true in the high-stakes world of biopharmaceutical companies. Three Fool.com contributors identified what they believe could be monster stocks in the making. Here's why these chose Axsome Therapeu...

2023-06-22 06:40:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With patent expirations around the corner, some of the biggest pharmaceutical and biotech companies will soon face generic competition, creating a big opportunity for these top biotech stocks...

2023-06-20 08:23:15 ET Last year was a big one for Axsome Therapeutics (NASDAQ: AXSM) . The biotech company specialized in central nervous system conditions launched its first two products and saw its share price increase by 100%. But a lot more could be on the horizon. Axsome i...

2023-06-17 05:17:00 ET Axsome Therapeutics (NASDAQ: AXSM) stock jumped more than 10% on June 14 after the company made its latest investor presentation public. The market was reacting to new estimates that suggest peak annual U.S. sales of up to $11.5 billion for the drugs it sells ...

2023-06-16 14:00:00 ET Axsome Therapeutics (NASDAQ: AXSM) started out last year as a small up-and-coming biotech company. It finished the year with a more than 100% gain, beating the bear market and crushing the S&P 500 . How did this happen? Axsome launched its first tw...

2023-06-15 14:00:00 ET The best biotech growth stocks typically have one clear-cut value driver. This fact is a testament to the extreme difficulty involved in bringing a major new drug to market and subsequently capturing market share. As a result, a large chunk of small- to mid-cap biotec...